Listen On
JAK

Definition of Remission in Rheumatoid Arthritis & Likelihood with Advanced Therapies

In this FAQ video module, Stacey Johnson, NP-C, explains the updated remission criteria for rheumatoid arthritis (RA), highlighting the 2022 Boolean 2.0 criteria and index-based definitions endorsed by the ACR and EULAR. Boolean 2.0 includes tender and swollen joint counts, patient global assessment, and CRP levels, allowing a patient global threshold of 2. It aligns more closely with the Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) remission criteria. The video also reviews recent trial data showing improved remission rates with Boolean 2.0, underscoring the need for continued advancements in RA treatment. Visit RhAPP’s Content Rheum for more educational resources on RA.

Related FAQ Video Module

Describe JAK-STAT signaling in inflammation

JAK

What is the ORAL Surveillance study and how can it be applied to clinical practice?

JAK

Variability in JAK Inhibition Specificity & Its Clinical Implications

JAK

Provide immunologic rationale for JAK directed therapy in rheumatic disease

JAK

Download the app and start using it now.

Download on the App Store GET IT ON Google Play